First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in advanced non-small cell lung cancer: a subanalysis of Asian patients in CheckMate 9LA

Thomas John, Hiroshi Sakai, Satoshi Ikeda, Ying Cheng, Kazuo Kasahara, Yuki Sato, Yoshiro Nakahara, Masayuki Takeda, Hiroyasu Kaneda, Helong Zhang, Makoto Maemondo, Koichi Minato, Takeshi Hisada, Yuki Misumi, Miyako Satouchi, Katsuyuki Hotta, Ang Li, Abderrahim Oukessou, Shun Lu

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in advanced non-small cell lung cancer: a subanalysis of Asian patients in CheckMate 9LA'. Together they form a unique fingerprint.

Medicine & Life Sciences